Asked by: Yasmin Qureshi (Labour - Bolton South East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make it her policy to commission an independent review of the Commission on Human Medicines’ Expert Working Group’s report on Hormone Pregnancy Tests.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
We remain hugely sympathetic to the families who believe that they have suffered as a result of using Hormone Pregnancy Tests. We have no plans to set up an independent review to examine the findings of the Expert Working Group. In the interests of transparency, all evidence collected and papers considered by the Expert Working Group were published in 2018, along with full minutes of its discussions. Details of conflicts of interests, and how these were managed, were also published.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that intensive therapy unit patients have access to rehabilitative therapies on their discharge from hospital.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
Rehabilitation, and therapy-led reablement, are critical in ensuring that patients discharged on intermediate care pathways from acute settings receive appropriate support to recover.
As set out in the hospital discharge and community support guidance, local authorities and integrated care boards should ensure that, where appropriate, they commission rehabilitation, including therapy-led reablement, for those who need it.
Every acute hospital now has access to a care transfer hub. These hubs bring together professionals from the National Health Service and social care to ensure that patients with more complex needs have in place the most appropriate support package for their safe discharge.
Asked by: Helen Grant (Conservative - Maidstone and The Weald)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what progress her Department has made on increasing access to dentists in Maidstone and the Weald constituency.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
In the 24 months to June 2023, 496,306 adults were seen by a National Health Service dentist in Kent and Medway Integrated Care Board (ICB). This figure is 12% higher than the year before, where 444,190 adults were seen by an NHS dentist, in the 24 months to June 2022.
On 7 February 2024, we published Faster, simpler, and fairer: our plan to recover and reform NHS dentistry, which is backed by £200 million and will fund approximately 2.5 million additional appointments. The plan sets out our actions to improve dental access for patients across the country to address the challenges facing NHS dentistry, including in Maidstone and the Weald.
A new patient premium is supporting dentists in taking on new patients, and a new marketing campaign will help everyone who needs an NHS dentist in finding one. We have further supported dentists by raising the minimum Units of Dental Activity rate to £28 this year, making NHS work more attractive and sustainable.
From 1 April 2023, the responsibility for commissioning primary care dentistry to meet the needs of the local population has been delegated to all ICBs across England. Kent and Medway ICB is responsible for having local processes in place to identify areas of need, and determine the priorities for investment across the ICB area.
Asked by: Helen Grant (Conservative - Maidstone and The Weald)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent progress she has made on retaining more GPs.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
There were 2,799 more full time equivalent (FTE) doctors working in general practice (GP) in December 2023, compared to December 2019. The Government is working with NHS England to increase the GP workforce in England. This includes measures to boost recruitment, address the reasons why doctors leave the profession, and encourage them to return to practice. NHS England has made available a number of retention schemes, to boost the GP workforce.
Asked by: Ellie Reeves (Labour - Lewisham West and Penge)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that NHS integrated care boards commission (a) end-of-life and (b) other palliative care for people in all age groups.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
While the National Health Service has always been required to commission appropriate palliative and end of life care services to meet the reasonable needs of their population, in 2022, palliative care services were added to the list of services an integrated care board (ICB) must commission, promoting a more consistent national approach and supporting commissioners in prioritising palliative and end of life care in all settings. To support ICBs in this duty, NHS England has published statutory guidance and service specifications for both adults and children.
From April 2024, NHS England will include palliative and end of life care in the list of topics for its regular performance discussions between national and regional leads. Additionally, NHS England has commissioned the development of a palliative and end of life care dashboard, which brings together relevant, all age local data in one place. The dashboard helps commissioners understand the palliative and end of life care needs of both adults and children in their local population, enabling ICBs to put plans in place to address and track the improvement of health inequalities.
NHS England has also funded seven Palliative and End of Life Care Strategic Clinical Networks, each with a dedicated Children and Young People Lead. These networks support commissioners in the delivery of outstanding clinical and personalised care for people in the last year of life and reduce local variation.
Asked by: Karin Smyth (Labour - Bristol South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential impact of capacity in district nursing on the timeliness of patient discharge from hospital in 2023.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
Between the end of March 2023 and the end of March 2024, the number of supported discharges for patients assessed as no longer meeting the criteria to reside has increased by 17% for patients on pathway 1. Pathway one is for patients returning to their usual place of residence with new or additional health or social care needs. Packages of post-discharge support for these patients may include support from district nurses.
We recognise the importance of increasing district nursing capacity. Through the NHS Long Term Workforce Plan we aim to increase training places for district nurses by 150% by 2031/32. As of January 2024, there were 4,295 full-time equivalent district nurses working in community services in NHS trusts and other core organisations in England, this is 0.5% fewer than in 2019.
Asked by: Karin Smyth (Labour - Bristol South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many children have been waiting longer than (a) 18 and (b) 24 months for a community paediatric appointment as of 17 April 2024.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
Monthly information on waiting lists and times for community health services in England can be found at the following link:
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what guidance her Department provides to NHS trusts on ensuring that patients transitioning from intensive care units to hospital wards receive the necessary specialist care on those wards.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
A quality standard for patient transfers, from critical care to general wards, has been published by the National Institute for Health and Care Excellence, and endorsed by NHS England. The quality standard, which emphasises the importance of continuity in rehabilitation, is available at the following link:
Asked by: Baroness Bennett of Manor Castle (Green Party - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to ensure minimal usage of helium in MRI scanners in NHS facilities in the light of the global shortage of helium; and what steps they are taking to ensure all helium in scanners being replaced is reused appropriately.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
Suppliers of magnetic resonance imaging (MRI) scanners are moving to a sealed helium solution, whereby the helium required to cool the magnet is approximately 0.5% of the current levels. These sealed systems will also ensure MRI scanners do not require further helium to be added during years of operational use.
Furthermore, suppliers are now replacing MRI scanners without requiring the magnet to be replaced, though this is only available for the first replacement cycle, whereby the scanner is fully replaced, but the existing magnet and helium are retained.
With regards to the Department, as set out in the recent Medical Technology Strategy: One Year On publication, the Design for Life Programme has been stood up to work with industry, the health and care sector, and academic partners to develop medical technology systems that support reuse, remanufacture, and material recovery becoming the default. This includes developing regulatory, commercial, digital, and policy environments that support this aim. The Department’s intention is to publish a roadmap later this year to articulate our relevant findings and plans moving forward.
Asked by: Baroness Goudie (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to ensure that the NHS is prepared for the arrival of new diagnostic innovations for dementia.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Health Service is a world leader in rolling out innovative treatments and has established a dedicated national programme team which is working in partnership with other national agencies and with local health systems to prepare for the potential roll out of new treatments for use in the earlier stages of Alzheimer’s disease. These plans assume that, if these new treatments are approved by the regulators, significant additional diagnostic capacity, including amyloid positron emission tomography–computed tomography, lumbar puncture and magnetic resonance imaging, will be needed both to identify patients who are most able to benefit and to provide important safety monitoring.
The national programme team is conducting preparations across the country, working alongside clinicians and local teams to identify where further funding will be required to roll out the additional tests and services needed to introduce these new and complex treatments.
NHS England is also working with partner agencies to support and inform further research into other diagnostic modalities, including blood-based biomarker and digital tests, which will help improve identification and management of Alzheimer’s disease.